您的位置: 首页 > 农业专利 > 详情页

COMPOSES DE BENZIMIDAZOLONE QUI PRESENTENT UNE ACTIVITE AU RECEPTEUR M1 ET LEURS UTILISATIONS EN MEDECINE
专利权人:
GLAXO GROUP LIMITED
发明人:
BUDZIK, BRIAN,COOPER, DAVID GWYN,FORBES, IAN THOMSON,GARZYA, VINCENZO,JIN, JIAN,SHI, DONGCHUAN,SMITH, PAUL WILLIAM,WALKER, GRAHAM
申请号:
CA2624504
公开号:
CA2624504C
申请日:
2006.09.27
申请国别(地区):
CA
年份:
2014
代理人:
摘要:
Compounds which have activity at M1 receptor and their uses in medicineCompounds of formula (I) and salts and solvates are provided: wherein R4 isfluoro, R5 is selected from hydrogen, halogen, cyano, C1-6alkyl, C1-6alkylsubstituted with one or more fluorine atoms, C1-6alkoxy, and C1-6alkoxysubstituted with one or more fluorine atoms; and R6 is selected from halogen,cyano, C1-6alkyl, C1-6alkyl substituted with one or more fluorine atoms, C3-6cycloalkyl, C3-6cycloalkyl substituted with one or more fluorine atoms, C1-6alkoxy and C1-6alkoxy substituted with one or more fluorine atoms, and Q ishydrogen or C1-6alkyl. The compounds are expected to be useful for therapy,for example in the treatment of psychotic disorders and cognitive impairment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充